Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P56851 (
epididymal
)
11,273
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pituitary adenylate cyclase-activating-polypeptide (PACAP) is a new member of the secretin/glucagon/vasoactive intestinal peptide family of peptides; it occurs as two amidated forms with 38 (
PACAP38
) and 27 (
PACAP27
) amino acids. Rabbit antisera against synthetic
PACAP27
were characterized by enzyme-linked immunosorbent assay. One of the antisera, using a high antibody titer, recognized both
PACAP27
and
PACAP38
and was found useful for immunohistochemistry. The distribution and ultrastructural localization of PACAP-like immunoreactivity (PACAP-LI) in the rat testes at different stages of spermatogenesis were studied with this antiserum. Four oligonucleotide probes, each complementary to a different region covering a different intron-exon junction, were chosen to maximize hybridization based on the predicted secondary structure of PACAP messenger RNA. PACAP-LI was detected in the developing germ cells but not in either Sertoli or Leydig cells. Intense PACAP-LI was found in spermatids situated near the lumen of the seminiferous tubules. Lower levels of PACAP-LI were detected in spermatogonia and primary spermatocytes, but no PACAP-LI was found in mature spermatids, testicular spermatozoa, or
epididymal
spermatozoa. In spermatids, PACAP-LI was detected during the cap phase and acrosome phase but not in the maturation phase. At the ultrastructural level, numerous gold particles representing PACAP-LI were found in both acrosomal granules and acrosomal caps of spermatids, while a few particles were found in the Golgi complex. Very few gold particles were seen in the acrosome of mature spermatids and spermatozoa. PACAP-LI decreased and finally disappeared from spermatids during the late developmental stages. In situ hybridization indicated that most of the signal was detected near the perimeter of seminiferous tubules in early developing germ cells, especially in spermatogonia and primary spermatocytes, suggesting that transcription of the PACAP gene occurs in spermatogonia and primary spermatocytes. The processing of the prohormone appears to be slow, and mature PACAP only appears in spermatids. These morphological findings suggest that PACAP-like substances, synthesized by germ cells, participate in spermatogenesis, particularly spermiogenesis, probably by an autocrine and paracrine mechanism. However, the possibility that PACAP acts on the Sertoli and/or Leydig cells cannot be excluded.
...
PMID:Localization of pituitary adenylate cyclase-activating polypeptide and its messenger ribonucleic acid in the rat testis by light and electron microscopic immunocytochemistry and in situ hybridization. 807 Mar 75
The present study investigated the role of
pituitary adenylate cyclase-activating polypeptide
(
PACAP
) in the regulation of electrogenic anion secretion by the rat cauda
epididymal
epithelium.
PACAP38
, which has been shown to affect secretory function in various exocrine and endocrine tissues, gave rise to a concentration-dependent increase in the short-circuit current (Isc). The
PACAP38
effect was restricted to the apical aspect of the
epididymal
cells. The Isc response to
PACAP38
was abolished in Cl-(-)free solution and completely inhibited by the Cl- channel blocker, diphenylamine-dicarboxylic acid. The Isc response to
PACAP38
was also suppressed by pretreatment of the cells with the adenylate cyclase inhibitor, MDL12330A. The localization of
PACAP38
was further investigated using an immunohistochemical technique.
PACAP38
immunoreactivity was observed in the cauda
epididymal
tubules as well as in the cultured epithelium, indicating its epithelial origin. The present results suggest that Cl- secretion in the epididymis may be regulated by
PACAP38
, which could be locally synthesized and released by the epithelial cells, in a paracrine or autocrine fashion.
...
PMID:Local regulation of epididymal anion secretion by pituitary adenylate cyclase-activating polypeptide. 937 15
Previous investigation has provided evidence for the control of electrogenic chloride secretion by
pituitary adenylate cyclase-activating polypeptide
(
PACAP
) across the rat
epididymal
epithelium using electrophysiological measurement of transepithelial transport in cultured
epididymal
system. Hence, it suggests that
epididymal
and sperm functions are subject to control by a local
PACAP
system in the rat epididymis. In the present study, localization and distribution of
PACAP
in the rat
epididymal
duct was studied by an indirect immunofluorescence technique in conjunction with confocal laser scanning microscopy. Immunoreactivity for
PACAP
was found in all regions of the
epididymal
duct. However, the intensity of immunoreactivity for
PACAP
was stronger in the caput and corpus regions when compared to that of the cauda epididymidis. Much weaker immunostaining for
PACAP
, as compared to those found in other regions, was observed in the cauda
epididymal
tubules which are in close proximity to the vas deferens. No immunoreactivity for
PACAP
was found in
epididymal
spermatozoa. Together with the previous finding, the present results suggest that
PACAP
may exhibit a regional difference in its expression along the
epididymal
duct and it may act in a paracrine or autocrine fashion in the regulation of
epididymal
chloride secretion and hence fluid secretion, thus regulating
epididymal
and sperm functions along the
epididymal
duct.
...
PMID:Localization and distribution of pituitary adenylate cyclase-activating polypeptide in the rat epididymis. 997 13
Pituitary adenylate cyclase-activating polypeptide
(
PACAP
) is synthesized in developing germ cells in the testis and may act as a paracrine modulator of spermatogenesis and/or participate in tubule-interstitial interactions. Despite the abundance of
PACAP
in the organ, its role in testicular function has not yet been studied in vivo. Using laser Doppler flowmetry, the effects of
PACAP
on blood flow in the testis and caput epididymidis were studied on anesthetized adult rats. When given intratesticularly as 5- and 50-ng doses,
PACAP
increased blood flow by 55+/-21% (mean +/- SEM, P < 0.05) and by 68+/-11% at 5 mm from the injection site, respectively. Whereas 5 ng
PACAP
did not influence blood flow 15 mm from the site of injection, flow was reduced (-7+/-3; P < 0.05) at this site following treatment with 50 ng. Injection of 50 ng
PACAP
into the caput epididymidis increased
epididymal
blood flow by 18+/-4% (P < 0.05) at 1 mm from the injection site. None of the treatments above significantly affected the mean arterial blood pressure. Using immunohistochemistry,
PACAP
was observed in elongated spermatids and in the acrosomes of round spermatids in some, but not all, seminiferous tubules. Also, distinct
PACAP
immunoreactivity was seen in epithelial cells, particularly in clear cells, of the caput epididymidis. In conclusion,
PACAP
can induce vasodilatation in both testicular and
epididymal
microvessels and may be involved in regulating blood flow in these organs. Whereas the vasodilatory effect of
PACAP
is strong in the testis, the
epididymal
response appears to be more moderate.
...
PMID:Pituitary adenylate cyclase-activating polypeptide (PACAP): effects on blood flow in the testis and caput epididymidis of the rat. 1038 16
There is growing evidence that secretin, the first hormone discovered in our history, has functions in the brain other than in the gastrointestinal tract. This article reports for the first time that secretin and its receptor mRNAs are produced in distinct cell types within the epididymis. To test if secretin affects electrolyte transport in the epididymis, we measured short-circuit current (Isc) in cultured
epididymal
epithelia and found secretin dose-dependently stimulated Isc. Ion substitution experiments and use of pharmacological agents inferred that the stimulated Isc is a result of concurrent electrogenic chloride and bicarbonate secretion. It is further shown that secretin and
pituitary adenylate cyclase-activating polypeptide
(
PACAP
) function via totally different mechanisms: 1)
PACAP
works only from the apical side of the epithelium to stimulate chloride and not bicarbonate secretion, while secretin acts on the apical and basolateral sides to stimulate chloride and bicarbonate secretion. 2) the stimulation by
PACAP
but not secretin requires local prostaglandin synthesis. By immunocytochemical staining, secretin is localized in the principal cells of the initial segment and caput epididymidis, whereas secretin receptor is present in the principal cells of the proximal as well as the distal part of the epididymis. This pattern of distribution appears to be consistent with the idea that secretin is secreted by the proximal epididymis and acts on the proximal and distal epididymis in an autocrine and paracrine fashion. Its function is to control secretion of electrolytes and water.
...
PMID:Secretin controls anion secretion in the rat epididymis in an autocrine/paracrine fashion. 1474 98
It was hypothesized that the VPAC1 agonist may exert anti-obesity functions because VPAC1 is involved in the anorexigenic effects and the anti-inflammatory function of
pituitary adenylate cyclase-activating polypeptide
(
PACAP
)/vasoactive intestinal polypeptide (VIP). Furthermore, our in vitro test showed that the expression of VPAC1 increased significantly after the 3T3-L1 adipocytes were differentiated, and that incubation of adipocytes with VPAC1 agonist (10-1 000 nmol/L per 1x10(6) cells) resulted in stimulation of lipolysis. To test the effect of VPAC1 agonist [Lys15, Arg16, Leu27]-VIP (1-7) GRF (8-27) on diet-induced obesity (DIO), we further designed the following two in vivo experiments: (1) Mice were fed on high-fat diet (HFD) and intraperitoneally (i.p.) treated with VPAC1 agonist simultaneously for 28 d; (2) Mice were given HFD for 35 d, and subsequently fed on the same HFD and i.p. treated with VPAC1 agonist for the next 28 d. The physiological indices, including body weight, weight of white adipose tissue, plasma glucose and blood lipid, were collected. The results showed that treatment with VPAC1 agonist inhibited ingestion significantly and prevented the elevations in body weight and the weights of the white adipose tissues (
epididymal
and dorsal) induced by HFD. The increases in plasma glucose, cholesterol, triglycerides and LDL induced by HFD were also down-regulated in mice treated with VPAC1 agonist. VPAC1 agonist treatment also improved the glucose tolerance. Therefore, VPAC1 agonist treatment inhibits the development of the obesity induced by HFD and helps to improve the morbidities associated with DIO.
...
PMID:In vivo anti-obesity effect of the agonist for receptor VPAC1. 1908 31
The developing acrosome in spermatids contains
pituitary adenylate cyclase-activating polypeptide
(
PACAP
). However, the role of the acrosomal
PACAP
remains unclear because it has not been detected in mature spermatids and sperm. We reinvestigated whether the sperm acrosome contains
PACAP
. An antiserum produced against
PACAP
reacted to the anterior acrosome in
epididymal
sperm fixed under mild conditions, suggesting that
PACAP
acts on oocytes and/or cumulus cells at the site of fertilization. Immunolabeling and RT-PCR demonstrated the presence of PACAP type I receptor, a
PACAP
-specific receptor, in postovulatory cumulus cells. To investigate the role of
PACAP
in fertilization, we pretreated cumulus-oocyte complexes with the polypeptide. At a low concentration of sperm, the fertilization rate was significantly enhanced by
PACAP
in a dose-dependent manner. Sperm penetration through the oocyte investment, cumulus layer, and zona pellucida was also enhanced by
PACAP
. The enhancement was probably due to an enhancement in sperm motility and the zona-induced acrosome reaction, which were stimulated by a cumulus cell-releasing factor. Indeed,
PACAP
treatment increased the secretion of progesterone from the cumulus-oocyte complexes. These results strongly suggest that in response to
PACAP
, cumulus cells release a soluble factor that probably stimulates sperm motility and the acrosome reaction, thereby promoting fertilization.
...
PMID:PACAP-mediated sperm-cumulus cell interaction promotes fertilization. 2107 64